(Taiwan) SHL expands drug delivery device manufacturing capacity in Taiwan :: BiotechEast - Taiwan and China biotechnology, medical devices, pharmaceuticals, ^¤å½s×, ^¤å×§ï ::

(BiotechEast staff)

20 October, 2009
Taoyuan, Taiwan-based SHL Group, a designer, developer and manufacturer of advanced drug delivery medical devices, including pen-injectors, auto-injectors and inhaler systems, celebrated its 20th anniversary with a ribbon-cutting event yesterday to open the expansion of the company's manufacturing facilities in Taiwan.

Roger Samuelsson provides product demonstrations to the Taoyuan Magistrate and Deputy Director General of Investment Services, MOEA. [SHL photo]

The expansion includes new machinery for tooling, CNC machining and automation. Together with the support of expatriate professionals, the expansion is expected to create new job openings and provide technology and expertise transferable to local staff in Taiwan.

With SHL announcing in 2008 its intention to invest US$100 million in new facilities and production in Taiwan over the following five years, this US$15 million 2000 square meter expansion project is a major part of this commitment, according to the company.

"We are excited to see our company continue to expand and grow. Our goal is to bring in the latest technologies and capabilities to SHL so that we can provide our customers with even more services. Now, SHL has over 1,500 staff globally with 1000 staff in Taiwan. And, I am pleased to announce that we will double in size over the next three years," said Roger Samuelsson, SHL Group founder and CEO,

The ribbon cutting ceremony featured guests from Taiwan's Ministry of Economic Affairs, Taoyuan Government, AMCHAM, ECCT and the Swedish Trade Council. After the ceremony, all the guests were taken on a private tour of the new facilities where millions of auto-injectors and pen-injectors are manufactured and distributed throughout the world.

Print this Article